Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Javelin Pharmaceuticals Inc: Premium Company Profile

Published by: Datamonitor

Published: Apr. 22, 2008 - 48 Pages


Table of Contents


Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Locations and Subsidiaries
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Business Segment Performance
Products & Services
Pipeline Products
AC Forecast Product Sales
Competitors and Strategic Business Relationships
Top Competitors
Key Suppliers
Key Clients
Shareholding Structure
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Sales
Scorecard
Overview
Scorecard Analysis
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
Appendix
Ask the analyst
Datamonitor consulting
Disclaimer
TABLE OF FIGURES
Figure 1: Javelin Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Figure 2: Javelin Pharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn)
TABLE OF TABLES
Table 1: Javelin Pharmaceuticals - Key Facts
Table 2: Javelin Pharmaceuticals - Other Locations and Subsidiaries
Table 3: Javelin Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
Table 4: Javelin Pharmaceuticals - Key Events Impacting Share Price Performance
Table 5: Javelin Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 6: Javelin Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 7: Javelin Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
Table 8: Javelin Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
Table 9: Javelin Pharmaceuticals - Revenue Breakdown, 2002-2006 ($ Mn)
Table 10: Javelin Pharmaceuticals - In-house Pipeline Products
Table 11: Javelin Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
Table 12: Javelin Pharmaceuticals - Top Competitors
Table 13: Javelin Pharmaceuticals - Key Suppliers
Table 14: Javelin Pharmaceuticals - Key Clients
Table 15: Javelin Pharmaceuticals - Key Shareholders
Table 16: Javelin Pharmaceuticals - SWOT Analysis Summary
Table 17: Javelin Pharmaceuticals - Value Chain Analysis
Table 18: Javelin Pharmaceuticals - Scorecard
Table 19: Javelin Pharmaceuticals - Key Employees
Table 20: Javelin Pharmaceuticals - Financial and Operational Overview


Abstract

Introduction

Javelin Pharmaceuticals is a late development stage specialty pharmaceutical company that discovers, develops and commercializes drugs and improved formulations of existing drugs that target pain management market.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Javelin Pharmaceuticals’ product candidates include Dyloject, which is in Phase III development stage for the treatment of post-operative pain in the US. It's pipeline also include Rylomine, an intranasal formulation of morphine that is in Phase III for the treatment of acute moderate-to-severe pain and breakthrough pain in the US and Europe; Javelin Pharmaceuticals derives its entire revenues from grants received from the US Department of Defense (DOD) and the National Institutes of Health (NIH) for the development and clinical advancement of PMI-150. The company’s total revenues increased at a CAGR of 31% during 2002-2006, from $0.3 million to $0.8 million. Javelin Pharmaceuticals is expected to witness an absolute growth of +$143 million with sales of $0.8 million in 2006 increasing to $143 million in 2010. The major contributor to this absolute growth is expected to be driven by the product launch of Dyloject in the year 2008 in most of the EU countries.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization .

Please note: This is delivered as a Zip file.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008